Dendreon makes leap to become cell therapy CMO

Dendreon makes leap to become cell therapy CMO

Source: 
Biopharma Reporter
snippet: 

Dendreon pivots to become a contract manufacturer of late-stage cell therapies, centered on its Seal Beach facility.